New Key Statistics Module, Z-Score and F-Score
HKSE:02315 Key Ratios
Market Cap HK$ M | 6,360.39 |
Enterprise Value HK$ M | 6,509.63 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 4.29 |
Price/Sales | 4.70 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) HK$ M | 784.00 |
EPS (TTM) HK$ | -1.05 |
Beneish M-Score | -2.79 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -21.97 |
EV-to-EBITDA | -21.97 |
PEG | -- |
Shares Outstanding M | 398.25 |
Net Margin (%) | -53.42 |
Operating Margin % | -42.69 |
Pre-tax Margin (%) | -53.03 |
Quick Ratio | 1.10 |
Current Ratio | 1.25 |
ROA % (ttm) | -14.31 |
ROE % (ttm) | -39.39 |
ROIC % (ttm) | -14.60 |
Dividend Yield % | -- |
Altman Z-Score | 1.14 |
HKSE:02315 Number of Guru Trades
HKSE:02315 Volume of Guru Trades
Gurus Latest Trades with HKSE:02315
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:02315 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Biocytogen Pharmaceuticals (Beijing) Co Ltd Insider Transactions
No Available Data